Stifel Financial’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding IDNA
WBG
Stifel Financial's IDNA Position: Q3 2026 in Review
Stifel Financial opened a new position in iShares Genomics Immunology and Healthcare ETF (IDNA) in Q3 2026: 20,798 shares worth $880K. The stake represents ﹤0.01% of the portfolio and ranks #2636 among its holdings. This is a return to the name: Stifel Financial previously reported a position in IDNA as recently as Q4 2021.
Stifel Financial first reported a position in IDNA in Q2 2020 and has held it in 8 quarters since. The position peaked at $1.71M in Q4 2020. 81 funds tracked by Wall St. Rank hold IDNA as of Q3 2026.
- Stifel Financial held 20,798 shares of iShares Genomics Immunology and Healthcare ETF worth $880K as of Q3 2026.
- iShares Genomics Immunology and Healthcare ETF was a new Stifel Financial position in Q3 2026.
- iShares Genomics Immunology and Healthcare ETF made up ﹤0.01% of Stifel Financial's portfolio in Q3 2026, its #2636 holding.
- Stifel Financial first reported a position in iShares Genomics Immunology and Healthcare ETF in Q2 2020 and has held it in 8 quarters since.
- Stifel Financial's iShares Genomics Immunology and Healthcare ETF position peaked at $1.71M in Q4 2020.
- 81 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q3 2026.
Based on Stifel Financial's 13F filing for Q3 2026, filed 12 Nov 2026.